scholarly journals Small Molecules and Big Killers: The Challenge of Eliminating the Latent HIV Reservoir

Immunity ◽  
2012 ◽  
Vol 36 (3) ◽  
pp. 320-321 ◽  
Author(s):  
Stephen A. Migueles ◽  
Mark Connors
Author(s):  
Niyati Jakharia ◽  
Adrian Majid ◽  
Bruce L. Gilliam ◽  
Rohit Talwani

Upon completion of this chapter, the reader should be able to to gain knowledge about new antiretroviral drugs in development, different strategies to restore the immune system and eliminate the latent HIV reservoir, and also discuss the role and current research of preventive and therapeutic vaccines....


JCI Insight ◽  
2020 ◽  
Vol 5 (4) ◽  
Author(s):  
Adit Dhummakupt ◽  
Jessica H. Rubens ◽  
Thuy Anderson ◽  
Laura Powell ◽  
Bareng A.S. Nonyane ◽  
...  
Keyword(s):  

2020 ◽  
Vol 222 (11) ◽  
pp. 1843-1852 ◽  
Author(s):  
Shane D Falcinelli ◽  
Bonnie E Shook-Sa ◽  
Morgan G Dewey ◽  
Sumati Sridhar ◽  
Jenna Read ◽  
...  

Abstract Background Persistent HIV infection of long-lived resting CD4 T cells, despite antiretroviral therapy (ART), remains a barrier to HIV cure. Women have a more robust type 1 interferon response during HIV infection relative to men, contributing to lower initial plasma viremia. As lower viremia during acute infection is associated with reduced frequency of latent HIV infection, we hypothesized that women on ART would have a lower frequency of latent HIV compared to men. Methods ART-suppressed, HIV seropositive women (n = 22) were matched 1:1 to 22 of 39 ART-suppressed men. We also compared the 22 women to all 39 men, adjusting for age and race as covariates. We measured the frequency of latent HIV using the quantitative viral outgrowth assay, the intact proviral DNA assay, and total HIV gag DNA. We also performed activation/exhaustion immunophenotyping on peripheral blood mononuclear cells and quantified interferon-stimulated gene (ISG) expression in CD4 T cells. Results We did not observe evident sex differences in the frequency of persistent HIV in resting CD4 T cells. Immunophenotyping and CD4 T-cell ISG expression analysis revealed marginal differences across the sexes. Conclusions Differences in HIV reservoir frequency and immune activation appear to be small across sexes during long-term suppressive therapy.


AIDS ◽  
2019 ◽  
Vol 33 (2) ◽  
pp. 211-218 ◽  
Author(s):  
Zabrina L. Brumme ◽  
Hanwei Sudderuddin ◽  
Carrie Ziemniak ◽  
Katherine Luzuriaga ◽  
Bradley R. Jones ◽  
...  

AIDS ◽  
2012 ◽  
Vol 26 (12) ◽  
pp. 1483-1490 ◽  
Author(s):  
Deborah Persaud ◽  
Paul E. Palumbo ◽  
Carrie Ziemniak ◽  
Michael D. Hughes ◽  
Carmelita G. Alvero ◽  
...  
Keyword(s):  
T Cell ◽  

2021 ◽  
Author(s):  
Saba Valadkhan ◽  
Leah Plasek ◽  
Lalith Gunawardane ◽  
Farshad Niazi ◽  
Sara Mason ◽  
...  

Abstract HIV persists in infected individuals despite effective antiretroviral therapy due to the rapid establishment of a latent HIV reservoir, mainly composed of quiescent memory CD4+ T cells1–3. The mechanisms governing the formation of the latent reservoir remain poorly understood. It is commonly assumed that entry of HIV into latency is a rare and random event associated with sporadic infection of effector T-cells transitioning to a memory phenotype4–8. Using human primary CD4+ T cell models, we show instead, that HIV infection itself triggers a strong transcriptomic remodeling that results in activation of a quiescence program, including downregulation of cellular proliferation and metabolic pathways. This transcriptional program is initiated by KLF2, a key regulator of quiescence, along with activation of the p53 pathway and downregulation of MYC. Loss and gain of function studies confirmed that KLF2 and p53 signaling are responsible for the downregulation of MYC and proliferation pathways, and consequently, proviral transcriptional silencing. Thus, HIV infection per se, enhances the formation of the latent reservoir in T-cells, ensuring viral persistence in infected individuals. These findings identify a new and unexpected mechanism for the formation of the latent HIV reservoir, and broaden the repertoire of strategies through which viruses can control the host cell to their advantage.


AIDS ◽  
2008 ◽  
Vol 22 (10) ◽  
pp. 1125-1129 ◽  
Author(s):  
Nathalie Sagot-Lerolle ◽  
Aurelia Lamine ◽  
Marie-Laure Chaix ◽  
Faroudy Boufassa ◽  
Jean-Paul Aboulker ◽  
...  

2021 ◽  
Author(s):  
Thomas A. Packard ◽  
Roland Schwarzer ◽  
Eytan Herzig ◽  
Deepashri Rao ◽  
Xiaoyu Luo ◽  
...  

ABSTRACTHIV infects long-lived CD4 memory T cells establishing a latent viral reservoir that necessitates lifelong anti-retroviral therapy (ART). How this reservoir is formed so swiftly remains unknown. We now show the innate inflammatory response to HIV infection results in CCL2 chemokine release, which can drive recruitment of cells expressing the CCR2 receptor including a subset of central memory CD4 T cells. Supporting a role for the CCL2/CCR2 axis in rapid reservoir formation, we find 1) treatment of humanized mice with anti-CCL2 antibodies during HIV infection decreases reservoir seeding and 2) CCR2/5+ cells from the blood of HIV-infected individuals on long term ART contain significantly more provirus than CCR2/5-negative memory or naïve cells. Together, these studies support a model where the host’s innate inflammatory CCL2 response to HIV infection recruits CCR2/5+ central memory CD4 T cells to zones of virus-associated inflammation likely contributing to rapid formation of the latent HIV reservoir.GRAPHICAL ABSTRACTWhy is the latent HIV reservoir established so early following infection? An innate immune response occurs during acute infection that establishes a “zone of inflammation” (step 1). The CCL2 chemokine is produced in part through IFI16 sensing of HIV DNA in abortively infected cells. CCL2 promotes rapid recruitment of CCR2/5+ memory CD4 T cells (step 2). Many of these cells become productively infected (step 3) and a fraction become latently infected (step 4). Thus, HIV hijacks the host inflammatory response to rapidly establish the latent reservoir. In support of this model, we find HIV reservoir reduction in humanized mice treated with anti-CCL2 antibodies during early infection. Further, we find that CCR2/5+ CD4 T cells harbor a substantial fraction of detectable proviruses in the blood of HIV-infected individuals on long-term suppressive ART.Abstract Figure


Sign in / Sign up

Export Citation Format

Share Document